In CAPTAIN prespecified analyses [ 27 ], there was a numerical trend for a greater reduction in moderate/severe attacks among ex-smokers versus patients without smoking history after adding UMEC to FF/VI, although, as with other studies, the number of ex-smokers was low versus the other subgroups, and smoking history was limited (i.e., < 10 pack years).
← all excerpts
Misconceptions of Traits to Predict Response to Inhaled Corticosteroid and Bronchodilator Therapies in Asthma: A Narrative Review.
2
—
—
The sentences
Addition of UMEC to FF/VI resulted in improvements in trough FEV 1 and FEV 1 3 h post dose (post hoc analysis) in both subgroup populations (consistent across FF 100 μg- and FF 200 μg-containing therapies) and attack rates (FF 100 μg-containing therapies), with a possible trend for greater numerical improvements in these outcomes in patients without a history of severe attacks (prespecified analysis).